Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing Tyvalzi™ in India

Posted On: 2023-09-14 15:01:03 (Time Zone: IST)


Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that one of its wholly-owned subsidiaries has entered into a license agreement with Pharmazz Inc., (Pharmazz), a U.S. based biopharmaceutical company to commercialise a first-in-class innovative drug, Tyvalzi™ (Sovateltide) in India. Developed by Pharmazz for potential global use, Sovateltide is indicated for treating cerebral ischemic stroke.

As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi™ (Sovateltide). Pharmazz will be entitled to upfront and milestone payments, including royalties.

Kirti Ganorkar, CEO - India Business, Sun Pharma said, "The Phase 3 clinical trial for Tyvalzi™ conducted in India demonstrated statistically and clinically meaningful improvement in neurological outcomes in ischemic stroke. Tyvalzi™ is a first-in-class innovative drug which can help improve the quality of life of stroke patients. The drug can be administered within 24 hours for the treatment of ischemic stroke. The current treatment options provide a narrow time window of 4-5 hours limiting its use in most patients."

Dr. B. S. Paul, a leading neuro-physician at Dayanand Medical College & Hospital, Ludhiana, who was a part of the clinical trials of Tyvalzi™ (Sovateltide), said, "No new drug other than rTPA has been approved for the treatment of stroke for more than two decades. The narrow time window of rTPA of 4.5 hours limits its use in a vast majority of patients with cerebral ischemic stroke. There is an urgent need for new therapies to treat stroke, the 2nd leading cause of mortality & morbidity worldwide. Sovateltide (TyvalziTM), a selective endothelin B receptor agonist, a new first-in-class drug recently approved for treating cerebral ischemic stroke, can be administered up to 24 hours post cerebral ischemic stroke. Sovateltide (TyvalziTM) produced statistically significant and clinically meaningful improvements in neurological outcomes at 90 days post-treatment in clinical trials as measured by the NIHSS, mRS, and B.I. scales. Sovateltide (TyvalziTM) is a neuronal progenitor cell therapy that promotes neurogenesis, angiogenesis, and synaptogenesis, thereby inducing neurovascular remodeling. I believe that Sovateltide (Tyvalzi™) is an exciting new, approved, effective, and well-tolerated therapy for treating cerebral ischemic stroke patients."

Dr. Prof. Anil Gulati, M.D., Ph.D., inventor, CEO, and Chairman of the Board of Directors of Pharmazz, said: "It is a significant step for Pharmazz to partner with Sun Pharma, the largest pharmaceutical company in India. For patients with cerebral ischemic stroke, I believe Sun Pharma is the best partner for Pharmazz to market TyvalziTM (Sovateltide), an innovative, first-in-class novel treatment for cerebral ischemic stroke, in India."

The global burden of disease project1 estimated the number of incident cases of stroke in India to be 1,175,778. In India, studies estimate that the incidence of stroke population varies from 116 to 163 per 100,000 population2. Stroke is the fourth leading cause of death and the fifth leading cause of disability3 in India. By 2050, more than 80% of the predicted global burden of new strokes of 15 million will occur in low and middle-income countries.

Sun Pharmaceutical is the owner of the brand name Tyvalzi™.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1148.00 as compared to the previous close of Rs. 1145.15. The total number of shares traded during the day was 188150 in over 8608 trades.

The stock hit an intraday high of Rs. 1156.95 and intraday low of 1142.75. The net turnover during the day was Rs. 216384836.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Nibe Ltd enters into collaboration agreement with Hewlett Packard Enterprise India Pvt Ltd

SAMHI Hotels Ltd closed at 17% premium to its issue price of Rs 126 per share

Delta Corp Limited gets notice to pay tax liability of Rs. 11139.61 crore

Karnataka Bank to raise up to ? 1,500 crores

Cosmic CRF Ltd bags order from Hindusthan Engineering & Industries Limited

Inox Green Energy Services Ltd to acquire majority stake in Resowi Energy Pvt Ltd

Hindustan Foods Ltd board approves fund raising through issue of convertible warrants

Regency Ceramics Ltd kickstarts its revival, commences product deliveries in Chennai

Cigniti Technologies Recognized as a Leader in Everest Group's Quality Engineering Services PEAK Matrix® Assessment 2023

SBI raises Rs. 10,000 crores through 4th infrastructure bond issue

Federal Bank Hosted a Cricket Extravaganza: ICC Men's Cricket World Cup Trophy Tour Arrived with a Bang!

Ircon International signs contract with Sri Lanka Railways, Ministry of Transport, Sri Lanka

Shop TJC, UK acquires assets of 'Ideal World'? a major teleshopping brand in UK

Lemon Tree Hotels launches its third property in Himachal Pradesh with Lemon Tree Hotel, Mcleodganj

Lancor Holdings Ltd receives Premium FSI approval from CMDA for Lancor Infinys at Keelkattalai

Zen Technologies Ltd receives order worth Rs. 227.65 crores

Central Bank of India enters into Co-Lending partnership with ECL Finance Ltd

KPI Green Energy Ltd receives LOI for 145.20 MW Hybrid Power Project

ANZ selects HCLTech to advance workplace experience

Crompton honored with Safe-Tech Award 2023 for championing safety awareness at its Baddi Plant

IRM, India Affiliate partners with Tata Consumer Products to integrate and strengthen Enterprise Risk Management in the FMCG sector

Shri Parshottam Rupala, Union Minister for Fisheries to launch SISTA360 at Seminar hosted by Kings Infra

Lupin acquires Five Brands from Menarini

Inflame Appliances Ltd announces partnership with Havells for Kitchen Aplliances

Syschem India Ltd approves 1:4 rights issue at Rs. 40 per share

NCC Ltd - J Kumar Infraprojects Ltd JV wins order worth Rs. 6301.08 crores

Lloyds Enterprises Ltd to acquire 7% stake in Lloyds Metals & Minerals Trading LLP

Diamines and Chemicals Limited gets listing approval from NSE

EQUIPPP welcomes Mr. Guruprasad Sowle as an Advisor

Suzlon secures an order of 29.4 MW from BrightNight

Wardwizard Group appoints new Leadership to drive Innovation in the Electric Vehicle Industry

HDFC Bank reduces stake in HOEC

ICICI Lombard General Insurance Company Ltd announces resignation of MD and CEO

IFC, Sunteck Realty Create Joint Platform to invest up to INR 7,500 million to Expand Green Urban Housing in Maharashtra

IndiGo and British Airways announce new codeshare partnership

NBCC India Ltd bags order from SAIL Bhilai Steel Plant

Muthoot Finance Ltd to raise ?700 crores through Public Issue of Secured Redeemable NCDs

HCLTech receives GSI Partner of the Year Award at Denodo DataFest 2023

Adani Kattupalli Port in association with Adani Foundation to set up a Community Hall at Sattankuppam village

ICRA Analytics Collaborates with FactSet to provide users with daily Security Level Valuation of fixed income securities

LIC increases stake in Gujarat Gas Ltd

Tamilnad Mercantile Bank says glitch in processing NACH credit file resulted in wrong credit

Wipro appoints Aparna C Iyer as Chief Financial Officer

Black Box strengthens India presence with new Center of Excellence

Innovative Ideals and Services India Ltd receives order of Rs. 35 lakhs

Natural Biogenex Pvt Ltd performs inauguration at Tumkur unit

SPEL Semiconductor Limited to sell 8.14 acres land in Maraimalai Nagar

DMR Hydroengineering & Infrastructures Ltd receives work order worth Rs. 12.50 lakhs

AVG Logistics Limited grabs Long term Business Order worth INR 72 Crore from India's leading FMCG Company

ideaForge Technology Ltd receives order worth Rs. 58 crores


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020